Csenge Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Csenge Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$432K	Sell	10,266 -1,236	-11%	-$39.4K	0.02%	505
2026 Q1	$304K	Buy	+11,502	New	+$337K	0.01%	551
2023 Q4	–	Sell	-7,192	Closed	-$200K	–	665
2023 Q3	$200K	Sell	7,192 -141	-2%	-$4.61K	0.01%	593
2023 Q2	$250K	Sell	7,333 -2,530	-26%	-$79.5K	0.02%	545
2023 Q1	$297K	Sell	9,863 -1,637	-14%	-$50.7K	0.02%	474
2022 Q4	$325K	Buy	11,500 +656	+6%	+$20.8K	0.03%	444
2022 Q3	$356K	Sell	10,844 -44	-0.4%	-$1.61K	0.03%	413
2022 Q2	$343K	Sell	10,888 -1,274	-10%	-$44.6K	0.03%	419
2022 Q1	$559K	Sell	12,162 -13,392	-52%	-$638K	0.04%	356
2021 Q4	$2.37M	Sell	25,554 -198	-0.8%	-$13.7K	0.21%	90
2021 Q3	$1.93M	Buy	25,752 +198	+0.8%	+$16.6K	0.16%	109
2021 Q2	$2.37M	Sell	25,554 -4,836	-16%	-$411K	0.21%	90
2021 Q1	$2.67M	Buy	30,390 +8,485	+39%	+$842K	0.27%	73
2020 Q4	$2.04M	Buy	21,905 +1,855	+9%	+$148K	0.24%	76
2020 Q3	$1.35M	Buy	+20,050	New	+$1.17M	0.18%	91

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Csenge Advisory Group's ARKG Position: Q2 2026 in Review

Csenge Advisory Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 11% in Q2 2026, selling an estimated $39.4K and leaving 10,266 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #505.

Csenge Advisory Group first reported a position in ARKG in Q3 2020 and has held it in 15 quarters since. The position peaked at $2.67M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Csenge Advisory Group held 10,266 shares of ARK Genomic Revolution ETF worth $432K as of Q2 2026.
Csenge Advisory Group sold 1,236 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $39.4K.
ARK Genomic Revolution ETF made up 0.02% of Csenge Advisory Group's portfolio in Q2 2026, its #505 holding.
Csenge Advisory Group first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 15 quarters since.
Csenge Advisory Group's ARK Genomic Revolution ETF position peaked at $2.67M in Q1 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.